Adenocyte
PrivateLast Round
Early Funding
May 26, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Adenocyte is a medical technology company that has developed a platform for the early detection of adenocarcinoma and its precursors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adenocyte Comparables
Compare Adenocyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lucky Loop Medical AB | 81% | |
| Limaca Medical | 74% | |
| Cook Group Incorporated | 69% |
Adenocyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 26, 2026 |
Adenocyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
| iGan Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 5, 2026
Grew 100% QoQ from 3 to 6 employees.
- May 26, 2026
$10M raised, led by iGan Partners.
Adenocyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adenocyte's valuation, stock price, and market status.
Is Adenocyte a public or private company?
Adenocyte is a private company.
What is the current stock price of Adenocyte?
Adenocyte is a private company, so its shares have no public market price. Caplight tracks Adenocyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adenocyte worth (valuation)?
Valuation information for Adenocyte is not publicly available.
Can I buy Adenocyte stock?
Adenocyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adenocyte's last funding round?
Adenocyte's most recent funding round was Early Funding on May 26, 2026.
Who are the main investors in Adenocyte?
Key investors in Adenocyte include iGan Partners.
Will Adenocyte IPO soon?
No public IPO plans have been announced for Adenocyte.
How can I track Adenocyte secondary market activity?
Caplight tracks bids, offers, and trades in Adenocyte's shares on secondary markets.